Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study

Medicin og biovidenskab

• Prostatic Neoplasms 100%
• Biomarkers 82%
• Random Allocation 44%
• Causality 31%
• Genome-Wide Association Study 23%
• Therapeutics 20%
• Cholesterol 16%
• Cholesterol Esters 13%
• Water-Electrolyte Balance 13%
• Metabolome 12%
• Prostate-Specific Antigen 11%
• Lipoproteins 10%
• Information Storage and Retrieval 10%
• Phospholipids 10%
• Fatty Acids 9%
• Case-Control Studies 9%
• Triglycerides 9%
• Amino Acids 8%
• Genome 7%
• Lipids 7%
• Neoplasms 3%